362 related articles for article (PubMed ID: 28430046)
1. An Outpatient Methadone Weaning Program by a Neonatal Intensive Care Unit for Neonatal Abstinence Syndrome.
Lai A; Philpot P; Boucher J; Meyer A
Popul Health Manag; 2017 Oct; 20(5):397-401. PubMed ID: 28430046
[TBL] [Abstract][Full Text] [Related]
2. The relationship between gestational age and the severity of neonatal abstinence syndrome.
Gibson KS; Stark S; Kumar D; Bailit JL
Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
[TBL] [Abstract][Full Text] [Related]
3. Neonatal Abstinence Syndrome: Influence of a Combined Inpatient/Outpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population.
Lee J; Hulman S; Musci M; Stang E
Popul Health Manag; 2015 Oct; 18(5):392-7. PubMed ID: 25803316
[TBL] [Abstract][Full Text] [Related]
4. A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome.
Hall ES; Isemann BT; Wexelblatt SL; Meinzen-Derr J; Wiles JR; Harvey S; Akinbi HT
J Pediatr; 2016 Mar; 170():39-44.e1. PubMed ID: 26703873
[TBL] [Abstract][Full Text] [Related]
5. Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting.
Backes CH; Backes CR; Gardner D; Nankervis CA; Giannone PJ; Cordero L
J Perinatol; 2012 Jun; 32(6):425-30. PubMed ID: 21852772
[TBL] [Abstract][Full Text] [Related]
6. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH
J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of a clinical pathway with methadone treatment protocol for treatment of neonatal abstinence syndrome following in utero drug exposure to substances of abuse*.
Bhatt-Mehta V; Ng CM; Schumacher RE
Pediatr Crit Care Med; 2014 Feb; 15(2):162-9. PubMed ID: 24141658
[TBL] [Abstract][Full Text] [Related]
8. Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome.
Young ME; Hager SJ; Spurlock D
Am J Health Syst Pharm; 2015 Dec; 72(23 Suppl 3):S162-7. PubMed ID: 26582303
[TBL] [Abstract][Full Text] [Related]
9. Treating Neonatal Abstinence Syndrome in a Rural Hospital: Lessons Learned.
Gadomski A; Riley M; Ramiza K; Onofrey L; Zinkievich R; Krupa N; Scribani M
Acad Pediatr; 2018; 18(4):425-429. PubMed ID: 29428413
[TBL] [Abstract][Full Text] [Related]
10. Maternal methadone treatment and neonatal abstinence syndrome.
Liu WF; Singh K; Faisal M; Li S
Am J Perinatol; 2015 Sep; 32(11):1078-86. PubMed ID: 25915141
[TBL] [Abstract][Full Text] [Related]
11. Outpatient Pharmacotherapy for Neonatal Abstinence Syndrome.
Maalouf FI; Cooper WO; Slaughter JC; Dudley J; Patrick SW
J Pediatr; 2018 Aug; 199():151-157.e1. PubMed ID: 29754866
[TBL] [Abstract][Full Text] [Related]
12. Opioid Utilization by Pregnant Women with Sickle Cell Disease and the Risk of Neonatal Abstinence Syndrome.
Nnoli A; Seligman NS; Dysart K; Baxter JK; Ballas SK
J Natl Med Assoc; 2018 Apr; 110(2):163-168. PubMed ID: 29580450
[TBL] [Abstract][Full Text] [Related]
13. Adverse neonatal outcomes associated with maternal severe mental health diagnoses and opioid use.
Ma J; Sahasranaman V; Kirby RS; Boaz T
J Perinatol; 2020 Oct; 40(10):1497-1505. PubMed ID: 32753708
[TBL] [Abstract][Full Text] [Related]
14. Morphine vs Methadone Treatment for Infants with Neonatal Abstinence Syndrome.
Tolia VN; Murthy K; Bennett MM; Greenberg RG; Benjamin DK; Smith PB; Clark RH
J Pediatr; 2018 Dec; 203():185-189. PubMed ID: 30220442
[TBL] [Abstract][Full Text] [Related]
15. Morphine and Methadone for Neonatal Abstinence Syndrome: A Systematic Review.
Slowiczek L; Hein DJ; Risoldi Cochrane Z; Gregory PJ
Neonatal Netw; 2018 Nov; 37(6):365-371. PubMed ID: 30567886
[TBL] [Abstract][Full Text] [Related]
16. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
[TBL] [Abstract][Full Text] [Related]
17. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome.
Hall ES; Wexelblatt SL; Crowley M; Grow JL; Jasin LR; Klebanoff MA; McClead RE; Meinzen-Derr J; Mohan VK; Stein H; Walsh MC;
Pediatrics; 2014 Aug; 134(2):e527-34. PubMed ID: 25070317
[TBL] [Abstract][Full Text] [Related]
18. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.
Davis JM; Shenberger J; Terrin N; Breeze JL; Hudak M; Wachman EM; Marro P; Oliveira EL; Harvey-Wilkes K; Czynski A; Engelhardt B; D'Apolito K; Bogen D; Lester B
JAMA Pediatr; 2018 Aug; 172(8):741-748. PubMed ID: 29913015
[TBL] [Abstract][Full Text] [Related]
20. Cohort Analysis of a Pharmacokinetic-Modeled Methadone Weaning Optimization for Neonatal Abstinence Syndrome.
Hall ES; Meinzen-Derr J; Wexelblatt SL
J Pediatr; 2015 Dec; 167(6):1221-5.e1. PubMed ID: 26477866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
